Who owns SWIXX BioPharma?

SWIXX BioPharma is currently owned by Merieux Equity Partners, through Mérieux Participations 3, since 2021.

When did Merieux Equity Partners acquire SWIXX BioPharma?

Merieux Equity Partners acquired SWIXX BioPharma in 2021 (active for 5 years).

Home/Companies/Healthcare/SWIXX BioPharma

SWIXX BioPharma

Healthcare·Europe·Active·5yr hold

SWIXX BioPharma is a healthcare company, headquartered in Europe.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Merieux Equity Partners

Key facts

HQEurope

SectorHealthcare

StatusActive

Pharmaceutical and biotech distribution platform across Central and Eastern Europe.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Biobest

Active

HealthcareEurope· 2022

Janvier Labs

Active

HealthcareEurope· 2022

Dental Monitoring

Active

HealthcareEurope

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated May 2026 · Sourced from public filings